-
November 9, 2023 FDA Sparks Debate Over the Role of Psychological Support In Psychedelic Clinical TrialsWhile clinical research furthers its quest in proving psychedelics’ potential in treating a variety of...
-
September 14, 2023 MDMA Successfully Treats PTSD in Another Phase 3 Trial Sponsored by MAPS"MDMA-assisted therapy for PTSD is on track to be considered for approval by the FDA...
-
June 30, 2023 The Biggest Psychedelic News Stories of the Week – June 30In yet another eventful week in the psychedelics sphere, more clear signs depict psychedelics’ popularity...
-
June 27, 2023 The FDA Issues Guidance on Designing Psychedelic Clinical TrialsThe Food and Drug Administration published a new draft guidance with the purpose to advise...
-
November 4, 2021 FDA Approves First Clinical Trial Using Naturally Sourced PsychedelicsThis trial, using Filament Health's botanical drug candidates, is the first to assess the direct...
-
October 29, 2021 Psychedelic Business Spotlight: October 29This week in psychedelic business news: MindMed's MDMA research pipeline to treat Autism Spectrum Disorder;...
-
October 26, 2021 FDA Authorizes Cybin Device to Quantify Psychedelics’ Effects on the Brain"This study of ketamine’s psychedelic effects while wearing headgear equipped with sensors to record brain...
-
August 4, 2021 FDA Green Lights Ketamine for Treatment of ALS"This designation not only expedites our regulatory, clinical, and product development plans but also validates...
